医生采用推动OpenEvidence估值升至150亿美元
总部位于迈阿密的OpenEvidence依靠广告运营，其聊天机器人可帮助医生检索医学期刊和临床指南。该公司9月融资2.5亿美元，估值达到150亿美元。公司称上月医生提交了逾4200万次提示，报道还称近三分之二美国医生使用该服务。OpenEvidence已将工具嵌入西奈山医疗系统、纪念斯隆凯特琳癌症中心和纽约大学朗贡医疗中心等机构的电子病历。临床评估结果不一：梅奥诊所一项小型研究在抽样的5个病例中发现了准确建议，但其他研究发现其临床基准表现弱于谷歌Gemini和OpenAI GPT。
估值、医生采用情况和医院集成表明，AI辅助医疗搜索已成为医疗健康领域的重要业务。不过，主要使用量和营收数据部分依赖公司或知情人士说法，其临床有效性证据也仍不一致。
Story text
Size Width * Links
* Subscribers only Learn more
Nearly two-thirds of US doctors are turning to an AI-powered search engine to make patient decisions, propelling a little-known tech startup to a $15 billion valuation while prompting a debate over the future of patient care.
Miami-based OpenEvidence, founded by serial entrepreneur Daniel Nadler in 2022, said that many of America’s 1 million physicians processed more than 42 million prompts last month. Doctors are using the company’s chatbot to scour medical journals and clinical guidelines to help diagnose and treat patients.
The ads-powered platform has grown largely by word of mouth, penetrating a sector where few tools have seen similar traction. “We’re the first viral consumer internet app in healthcare,” Nadler told the FT in an interview.
#OpenEvidence#OpenAI#Anthropic#Google Gemini#OpenAI GPT#Mount Sinai Health System#Memorial Sloan Kettering Cancer Center#NYU Langone#Mayo Clinic#Wolters Kluwer#UpToDate#Claude Science